|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 35/16 | |
| A61P 7/02 |
| (11) | Patento numeris | 1696940 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 04804944.9 |
| Europos patento paraiškos padavimo data | 2004-12-20 | |
| (97) | Europos patento paraiškos paskelbimo data | 2006-09-06 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2007-03-21 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2004/053608 |
| Data | 2004-12-20 |
| (87) | Numeris | WO 2005/058334 |
| Data | 2005-06-30 |
| (30) | Numeris | Data | Šalis |
| 03029359 | 2003-12-19 | EP |
| (72) |
HEGER, Andrea, AT
RÖMISCH, Jürgen, AT
SVAE, Tor-Einar, AT
MARGUERRE, Wolfgang, DE
|
| (73) |
Octapharma AG,
Seidenstrasse 2, 8853 Lachen,
CH
|
| (54) | A UNIVERSALLY APPLICABLE VIRUS INACTIVATED BLOOD PLASMA PRODUCED FROM PORTIONS OF NON-CAUCASIAN PLASMA |
| A UNIVERSALLY APPLICABLE VIRUS INACTIVATED BLOOD PLASMA PRODUCED FROM PORTIONS OF NON-CAUCASIAN PLASMA |